|Articles|May 8, 2019

6 in 10 Infectious Diseases in Humans Are Zoonotic; CDC Report Lists Top US Threats

Plague. West Nile Virus. Zoonotic influenza. What else made the CDC list of the top 8 zoonotic diseases of most concern in the US?

Six in 10 infectious diseases in people are zoonotic, a first-ever report from the US Centers for Disease Control and Prevention (CDC) and its US government partners announced this week, along with a list of the top 8 diseases shared between animals and people of most concern in the United States.

The report, which prioritizes zoonotic diseases based on feedback from December 2017’s One Health Zoonotic Disease Prioritization Workshop for the United States workshop, was compiled by the CDC, US Department of Agriculture (USDA), and the US Department of the Interior (DOI).

“Every year, tens of thousands of Americans get sick from diseases spread between animals and people. CDC’s One Health Office is collaborating with DOI, USDA, and other partners across the government to bring together disease detectives, laboratorians, physicians, and veterinarians to prevent those illnesses and protect the health of people, animals, and our environment,” Casey Barton Behravesh, MS, DVM, DrPH, director of the CDC’s One Health Office, said in a press release.

According to the report, the top 8 zoonotic diseases of most concern in the US are:

  • Zoonotic influenza (zoonotic influenza A viruses)
  • Salmonellosis (Salmonella species)
  • West Nile virus (Flaviviridae, Flavivirus)
  • Plague (Yersinia pestis)
  • Emerging coronaviruses (eg., severe acute respiratory syndrome and Middle East respiratory syndrome)
  • Rabies (Rhabdoviridae, Lyssavirus)
  • Brucellosis (Brucella species)
  • Lyme disease (Borrelia burgdorferi)

“The top priority for preventing zoonotic diseases already circulating in the US will be to inform people in contact with animals (occasional, [such as] visitors zoo or natural parks; pet owners; professional, etc.) about the zoonotic risks,” Jean-Paul J. Gonzalez, MD, PhD, deputy director of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) at Kansas State University and Contagion® Editorial Advisory Board member, said in an interview.

Next steps will revolve around increasing and leveraging leadership engagement; developing a national One Health framework; creating a formalized One Health coordination mechanism at the federal level; and improving knowledge and data sharing for laboratory, surveillance, and response activities.

The One Health approach “recognizes the connection between people, animals, plants, and their shared environment and calls for experts in human, animal, and environmental health to work together to achieve the best health outcomes for all,” according to the CDC.


Related to this article

CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.